MEDI logo

Medistim ASA Stock Price

OB:MEDI Community·NOK 4.1b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 21 Fair Values set on narratives written by author

MEDI Share Price Performance

NOK 0
-220.00 (-100.00%)
NOK 315.00
Fair Value
NOK 0
-220.00 (-100.00%)
Price NOK 0

MEDI Community Narratives

·
Fair Value NOK 315 29.2% undervalued intrinsic discount

Share Repurchases and Market Expansion Will Support Stronger Future Performance

1users have liked this narrative
0users have commented on this narrative
8users have followed this narrative
·
Fair Value NOK 310 28.1% undervalued intrinsic discount

Rising Cost Pressures And Declining Patient Pools Will Curtail Potential

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
·
Fair Value NOK 320 30.3% undervalued intrinsic discount

Aging Global Populations And INTUI Upgrades Will Expand Adoption

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Trending Discussion

No trending discussion available.

Updated Narratives

MEDI logo

MEDI: Higher Future P/E Will Support Attractive Long Term Undervaluation

Fair Value: NOK 310 28.1% undervalued intrinsic discount
3 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
MEDI logo

MEDI: Stable Cash Generation And Dividend Prospects Will Support Future Performance

Fair Value: NOK 315 29.2% undervalued intrinsic discount
8 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
MEDI logo

MEDI: Stable Fair Value And Margins Will Support Future Upside

Fair Value: NOK 320 30.3% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Outstanding track record with flawless balance sheet.

1 Risk
3 Rewards

Medistim ASA Key Details

NOK 719.9m

Revenue

NOK 138.8m

Cost of Revenue

NOK 581.1m

Gross Profit

NOK 425.0m

Other Expenses

NOK 156.1m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 19, 2026
8.53
80.71%
21.68%
0%
View Full Analysis

About MEDI

Founded
1984
Employees
159
CEO
Kari Krogstad
WebsiteView website
www.medistim.com

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and ultrasound imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which are designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation; ultrasound imaging probes; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.

Medistim ASA Competitors